PRODUCT LIST

RELATED PRODUCTS

Download CATALOGUE

Position:HOME > Product

Ulipristal Acetate

Payment
T/T, west union, money gram,paypal
Delivery
within 3-5 working days
Origin
China
Packaging
1kg/bag or as required
Inspection
HPLC,UV
Samples
Free
COA
sales@nitobioc.com
Purity
99%
Standard
ES

Product Description
Ulipristal acetate (trade name EllaOne in the European Union, Ella in the U.S. for contraception,and Esmya for uterine fibroid) is a selective progesterone receptor modulator (SPRM).

NITO Safe Delivery
---- SAFTY COMES FIRST !
Considering steroids are very special in some countries, NITO will supply professional suggestion for package+label+documents+transport mode, to ensure goods arrive safely and smoothly without and trouble.

Product Feature
Product name: Ulipristal Acetate
English Name: (11b)-17-(Acetyloxy)-11-[4-(dimethylamino)phenyl]-19-norpregna-4,9-diene-3,20-dione
CAS: 126784-99-4
EINECS: 200-835-2
Formula: C28H35NO3
MW: 433.5824
 
Product Specification / Models
Purity: 99%min
Appearance:white powder.
Packing: 1kg/bag or as required.
Storage: Store in cool and dry area and keep away from direct sunlight.
Shelf life: 2 years, if keep in formal storage condition.

Application
Emergency contraception
For emergency contraception a 30 mg tablet is used within 120 hours (5 days) after an unprotected intercourse or contraceptive failure.It has been shown to prevent about 62-85% of expected pregnancies, and prevents more pregnancies than emergency contraception with levonorgestrel. Ulipristal acetate is available by prescription for emergency contraception in over 50 countries, with access through pharmacists without a prescription being tested in the United Kingdom.From July 2016 available without prescription in Israel.

Treatment of uterine fibroids
Ulipristal acetate is used for preoperative treatment of moderate to severe symptoms of uterine fibroids in adult women of reproductive age in a daily dose of a 5 mg tablet.

Treatment of uterine fibroids with ulipristal acetate for 13 weeks effectively controlled excessive bleeding due to uterine fibroids and reduced the size of the fibroids.

Two intermittent 3-months treatment courses of ulipristal acetate 10 mg resulted in amenorrhea at the end of the first treatment course in 79.5%, at the end of the second course in 88.5% of subjects. Mean myoma volume reduction observed during the first treatment course (-41.9%) was maintained during the second one (-43.7%). After two to four 3-months courses of treatment, UPA-treated fibroids shown about -70% in volume reduction. This phenomenon was temptatively explained by the combination of multifactorial events involving control of proliferation of the tumor cells, induction of apoptosis and remodeling of the extracellular matrix.

RELATIVE PRODCTS:
Tamoxifen         10540-29-1
Tadanafil         171596-29-5
Ulipristal Acetate 126784-99-4
 

NITO BIOC CO., LIMITED

Tel: +86-151 5243 9375
Fax: +86-513 5508 6165
QQ:2675661870

Skype: BiocNITO
E-mail: sales@nitobioc.com
Web: www.nitobioc.com
address

Zifeng Technology Parks, Yuanxing Road,  Nantong 226000, Jiangsu, China.

follow us
  •  
© 2015 "NITO BIOC CO., LIMITED"
ORDER CALL
Leave us your details and our manager will contact you at your convenience